|
Market Closed -
NYSE
04:00:02 2026-08-07 pm EDT
|
5-day change
|
1st Jan Change
|
|
352.47 USD
|
+2.93%
|
|
+8.29%
|
+16.33%
|
| 08:20am |
RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating
|
MT
| |
Aug. 05 |
RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating
|
MT
| |
Aug. 04 |
Bio Rad Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
|
PU
| |
Aug. 04 |
Bio-Rad Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026
| | |
Aug. 04 |
Bio-Rad: Q2 Earnings Snapshot
|
AQ
| |
Aug. 04 |
Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls
|
MT
| |
Aug. 04 |
Bio-Rad Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of 2026
|
CI
| |
Aug. 04 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M
|
MT
| |
Aug. 04 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75
|
MT
| |
Aug. 04 |
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
|
CI
| |
Aug. 04 |
Bio-Rad Reports Second-Quarter 2026 Financial Results
|
BU
| |
Jul. 23 |
Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
|
BU
| |
Jun. 03 |
Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
| | |
May. 19 |
Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM
| | |
May. 18 |
Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround
|
MT
| |
May. 18 |
Elliott Investment Management LP Urges Improvement In Share Price And Value Creation for Shareholders
|
CI
| |
May. 17 |
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports
|
RE
| |
May. 17 |
Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports
|
RE
| |
May. 17 |
Activist Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories - WSJ
|
RE
| |
May. 15 |
Bio-Rad Laboratories' Sales Growth Set to Recover in 2027, RBC Says
|
MT
| |
May. 11 |
Bio-Rad to Participate in Upcoming Investor Conferences
|
AQ
| |
May. 08 |
Bio-Rad to Participate in Upcoming Investor Conferences
|
BU
| |
May. 01 |
Bio-Rad Laboratories, Inc., Q1 2026 Earnings Call, Apr 30, 2026
| | |
Apr. 30 |
Bio Rad Laboratories : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)
|
PU
| |
Apr. 30 |
Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions |